| Item Type | Name |
|
Concept
|
Simvastatin
|
|
Academic Article
|
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.
|
|
Academic Article
|
Statin trials in progress: unanswered questions.
|
|
Academic Article
|
A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
|
|
Academic Article
|
The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin.
|
|
Academic Article
|
Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
|
|
Academic Article
|
A look to the future: new treatment guidelines and a perspective on statins.
|
|
Academic Article
|
Effects of simvastatin (40 and 80 mg/day) in patients with mixed hyperlipidemia.
|
|
Academic Article
|
Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia.
|
|
Academic Article
|
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia.
|
|
Academic Article
|
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels.
|
|
Academic Article
|
Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.
|
|
Academic Article
|
Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia.
|
|
Academic Article
|
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).
|
|
Academic Article
|
Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia.
|
|
Academic Article
|
Simvastatin plus ezetimibe: combination therapy for the management of dyslipidaemia.
|
|
Academic Article
|
Striated muscle safety of ezetimibe/simvastatin (Vytorin).
|
|
Academic Article
|
Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
|
|
Academic Article
|
Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).
|
|
Academic Article
|
Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
|
|
Academic Article
|
Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
|
|
Academic Article
|
Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
|
|
Academic Article
|
Baseline lipoprotein lipids and low-density lipoprotein cholesterol response to prescription omega-3 acid ethyl ester added to Simvastatin therapy.
|
|
Academic Article
|
Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.
|
|
Academic Article
|
Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
|
|
Academic Article
|
Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
|
|
Academic Article
|
Comparison of the efficacy and safety of a combination tablet of niacin extended-release and simvastatin with simvastatin 80 mg monotherapy: the SEACOAST II (high-dose) study.
|
|
Academic Article
|
High-dose statins in acute coronary syndromes.
|
|
Academic Article
|
Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting.
|
|
Academic Article
|
Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction.
|
|
Academic Article
|
Is ezetimibe/simvastatin no better than simvastatin alone? Lessons learned and clinical implications.
|
|
Academic Article
|
Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme.
|
|
Academic Article
|
Effects of raloxifene and low-dose simvastatin coadministration on plasma lipids in postmenopausal women with primary hypercholesterolemia.
|
|
Academic Article
|
Effect of ezetimibe/simvastatin versus atorvastatin or rosuvastatin on modifying lipid profiles in patients with diabetes, metabolic syndrome, or neither: Results of two subgroup analyses.
|
|
Academic Article
|
The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day.
|
|
Academic Article
|
Separate and joint effects of marine oil and simvastatin in patients with combined hyperlipidemia.
|
|
Academic Article
|
Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group.
|
|
Academic Article
|
Efficacy of simvastatin and ezetimibe in treating hypercholesterolemia.
|
|
Academic Article
|
Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: results of the Comparative HDL Efficacy and Safety Study (CHESS).
|
|
Academic Article
|
Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups.
|
|
Academic Article
|
Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study.
|
|
Academic Article
|
Is it over for ezetimibe?
|
|
Academic Article
|
Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein.
|
|
Academic Article
|
Lipid-altering efficacy and safety profile of co-administered extended release niacin/laropiprant and simvastatin versus atorvastatin in patients with mixed hyperlipidemia.
|
|
Academic Article
|
No Effect of Omega-3 Carboxylic Acids on Pharmacokinetics/Pharmacodynamics of Warfarin or on Platelet Function When Co-administered with Acetylsalicylic Acid: Results of Two Phase I Studies in Healthy Volunteers.
|
|
Academic Article
|
Assessment of pharmacokinetic interaction between omega-3 carboxylic acids and the statins rosuvastatin and simvastatin: Results of 2 phase I studies in healthy volunteers.
|
|
Academic Article
|
Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
|
|
Academic Article
|
Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapy.
|
|
Concept
|
Ezetimibe, Simvastatin Drug Combination
|